+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Remifentanil"

Anesthetics Global Market Report 2024 - Product Thumbnail Image

Anesthetics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
General Anesthesia Drugs - Global Strategic Business Report - Product Thumbnail Image

General Anesthesia Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
From
From
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Remifentanil is an opioid analgesic drug used in anesthetic drugs. It is a short-acting, synthetic opioid that is used to provide sedation and analgesia during medical procedures. It is a mu-opioid receptor agonist, meaning it binds to the mu-opioid receptor in the brain to produce its effects. Remifentanil is used in combination with other anesthetic drugs to provide a balanced anesthetic effect. It is also used to provide sedation and analgesia during labor and delivery. Remifentanil is a fast-acting drug, with a rapid onset of action and a short duration of action. It is metabolized quickly by the body, making it a safe and effective option for anesthetic drugs. Some companies in the Remifentanil market include Mylan, Fresenius Kabi, Hospira, and Teva Pharmaceuticals. Show Less Read more